We
Areca Financial Services
We are an all-in-one financial and capital markets platform capable of processing any type and size transaction seamlessly, quick placement, and secure investment distribution.
​
Our transaction advisory team is dedicated to surpassing client expectations by delivering expert advice and flawless execution in merger & acquisitions (M&A), corporate finance fund-raising, restructuring and capital-intensive projects.
​
We specialize in Biosciences, Health-tech, Aerospace, Defense-tech, SaaS Cybersecurity, Fintech and Alternative Energy, combined with over thirty years of capital and private markets expertise, allows us to craft tailored solutions for each client.
​
Collaborating closely with our equity research analysts and equity capital markets group partners, we can identify niche opportunities, challenging conventional wisdom with independent research, top analysts, and the highest standards of ethics and integrity.
Management
Henryk Dabrowski
CEO
Henryk Dabrowski boasts 30+ years of leading multinational ventures in technology, real estate, fintech, blockchain, and mobile payments. Over 30 years, he has invested globally in public and private firms, with expertise in capital markets, organizational development, investment banking, financial services, and venture capital, private equity, and institutional investor financing. He has extensive experience in Aerospace, Energy, Telecommunications, Crypto, Blockchain, and Fintech. Concurrently, he is the CEO of X-trategy Consulting Group, and Principal Partner in F3 Funds and STX Aerospace Ventures. ​
Pilar Vargas
Vice President
Capital & Deal Origination
Mrs. Vargas is a seasoned Capital Finder, specializing in raising funds for companies from Seed and beyond, including pre-IPO. With a proven track record connecting businesses with the right investors, she bridges visionary ideas with the capital needed to scale and succeed. Mrs. Vargas has successfully managed cross-border transactions and complex capital raises, bringing a strong track record in M&A and alternative investments. Her deep understanding of global financial markets and institutional investor dynamics makes her a trusted advisor. Building on a 25-year career as a journalist, she leverages this experience to navigate modern fundraising trends—crafting compelling narratives and investor communications that drive engagement and investment.
Tatiana Yglesias
Director
Life Sciences & Healthcare Investments
Ms. Yglesias brings nearly 20 years of experience in biopharma commercialization, venture capital, and business development. As Chief Business Officer at Saya Biologics, she led U.S. commercial strategy, partnerships, and capital planning with expansion into Latin America. During more than 12 years at Novartis, she managed a nearly $1B brand, launched products, and led cross-border commercial initiatives. She also established Portal Innovations’ Boston hub and advises investment banks on healthcare transactions and market diligence. Ms. Yglesias is Founder of Supra Advisory, leads the Boston Chapter of VNTR, serves on the boards of Latinos in Bio and the Women's Foundation of Massachusetts, and was named to The BLOC100 (2025).
